Elanco Animal Health Incorporated (NYSE: ELAN) announced Monday that the European Commission (EC) has granted approval of ElancoÕs pending acquisition of Bayer AGÕs (ETR: BAYN) animal health business. The company continues to progress toward a mid-year closing, anticipated August 3, 2020.
Read the full article: Elanco Announces European Commission Approval of Pending Acquisition of Bayer Animal Health //
Source: https://www.businesswire.com/news/home/20200608005476/en/Elanco-Announces-European-Commission-Approval-Pending-Acquisition